A detailed history of Raymond James & Associates transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Raymond James & Associates holds 77,545 shares of WST stock, worth $25.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
77,545
Previous 75,836 2.25%
Holding current value
$25.9 Million
Previous $25 Million 6.82%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$277.16 - $333.3 $473,666 - $569,609
1,709 Added 2.25%
77,545 $23.3 Million
Q2 2024

Jul 19, 2024

BUY
$314.68 - $395.94 $1.97 Million - $2.48 Million
6,256 Added 8.99%
75,836 $25 Million
Q1 2024

Apr 22, 2024

SELL
$338.27 - $413.0 $128,880 - $157,353
-381 Reduced 0.54%
69,580 $27.5 Million
Q4 2023

Jan 16, 2024

BUY
$318.29 - $392.21 $1.77 Million - $2.18 Million
5,564 Added 8.64%
69,961 $24.6 Million
Q3 2023

Oct 24, 2023

BUY
$354.9 - $412.41 $763,035 - $886,681
2,150 Added 3.45%
64,397 $24.2 Million
Q2 2023

Jul 25, 2023

SELL
$334.63 - $382.47 $366,419 - $418,804
-1,095 Reduced 1.73%
62,247 $23.8 Million
Q1 2023

Apr 14, 2023

BUY
$232.5 - $346.47 $1.3 Million - $1.94 Million
5,601 Added 9.7%
63,342 $21.9 Million
Q4 2022

Feb 08, 2023

SELL
$209.34 - $261.61 $118,277 - $147,809
-565 Reduced 0.97%
57,741 $13.6 Million
Q3 2022

Oct 25, 2022

SELL
$246.08 - $343.65 $2.54 Million - $3.54 Million
-10,304 Reduced 15.02%
58,306 $14.3 Million
Q2 2022

Aug 12, 2022

SELL
$280.61 - $420.45 $1.49 Million - $2.23 Million
-5,302 Reduced 7.17%
68,610 $20.7 Million
Q1 2022

May 11, 2022

BUY
$357.49 - $445.92 $566,264 - $706,337
1,584 Added 2.19%
73,912 $30.4 Million
Q4 2021

Feb 08, 2022

SELL
$402.25 - $471.34 $696,294 - $815,889
-1,731 Reduced 2.34%
72,328 $33.9 Million
Q3 2021

Nov 02, 2021

BUY
$363.01 - $468.47 $751,793 - $970,201
2,071 Added 2.88%
74,059 $31.4 Million
Q2 2021

Aug 11, 2021

SELL
$284.77 - $363.2 $231,233 - $294,918
-812 Reduced 1.12%
71,988 $25.9 Million
Q1 2021

May 14, 2021

BUY
$257.29 - $307.53 $3.95 Million - $4.73 Million
15,370 Added 26.76%
72,800 $20.5 Million
Q4 2020

Feb 12, 2021

SELL
$261.16 - $301.66 $632,529 - $730,620
-2,422 Reduced 4.05%
57,430 $16.3 Million
Q3 2020

Nov 04, 2020

BUY
$224.99 - $288.02 $2.21 Million - $2.83 Million
9,824 Added 19.64%
59,852 $16.5 Million
Q2 2020

Jul 28, 2020

BUY
$149.8 - $227.17 $1.82 Million - $2.76 Million
12,170 Added 32.15%
50,028 $11.4 Million
Q1 2020

Apr 21, 2020

SELL
$128.96 - $174.76 $271,460 - $367,869
-2,105 Reduced 5.27%
37,858 $5.76 Million
Q4 2019

Feb 12, 2020

BUY
$137.6 - $151.21 $30,272 - $33,266
220 Added 0.55%
39,963 $6.01 Million
Q3 2019

Nov 07, 2019

SELL
$121.41 - $150.02 $696,771 - $860,964
-5,739 Reduced 12.62%
39,743 $5.64 Million
Q2 2019

Aug 06, 2019

SELL
$111.27 - $125.15 $133,635 - $150,305
-1,201 Reduced 2.57%
45,482 $5.69 Million
Q1 2019

May 06, 2019

BUY
$94.53 - $110.2 $205,035 - $239,023
2,169 Added 4.87%
46,683 $5.15 Million
Q4 2018

Feb 11, 2019

SELL
$93.0 - $123.98 $16,554 - $22,068
-178 Reduced 0.4%
44,514 $4.36 Million
Q3 2018

Nov 14, 2018

SELL
$98.01 - $123.47 $2.13 Million - $2.69 Million
-21,777 Reduced 32.76%
44,692 $5.52 Million
Q2 2018

Aug 14, 2018

SELL
$83.32 - $101.88 $521,416 - $637,565
-6,258 Reduced 8.6%
66,469 $6.6 Million
Q1 2018

May 14, 2018

BUY
$85.56 - $102.4 $134,671 - $161,177
1,574 Added 2.21%
72,727 $6.42 Million
Q4 2017

Feb 14, 2018

BUY
$91.65 - $101.65 $131,609 - $145,969
1,436 Added 2.06%
71,153 $7.02 Million
Q3 2017

Nov 13, 2017

SELL
$84.54 - $96.75 $45,482 - $52,051
-538 Reduced 0.77%
69,717 $6.71 Million
Q2 2017

Aug 14, 2017

BUY
N/A
70,255
70,255 $6.64 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.